LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ) Insider Trading
Directors, officers and holders of more than 10% of LENZ report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 78 transactions on file: 6 with code P, 28 with code S and 16 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | S Sale | 451,998 | $3.36 | $1,518,713 |
| Oct 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | S Sale | 2,159,516 | $3.36 | $7,255,974 |
| Oct 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | S Sale | 107,170 | $3.36 | $360,091 |
| Jun 15, 2026 | George Jeffrey P. | Director | A Award | 22,100 | Not measured | Not measured |
| Jun 15, 2026 | Scheiner Zachary | Director | A Award | 22,100 | Not measured | Not measured |
| Jun 15, 2026 | Thunen Shelley B | Director | A Award | 22,100 | Not measured | Not measured |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | A Award | 22,100 | Not measured | Not measured |
| Jun 15, 2026 | Drapkin Kimberlee C | Director | A Award | 22,100 | Not measured | Not measured |
| Jun 15, 2026 | MCCOLLUM JAMES W | Director | A Award | 22,100 | Not measured | Not measured |
| Jun 15, 2026 | Guerard Frederic | Director | A Award | 22,100 | Not measured | Not measured |
| Mar 27, 2026 | Chevallard Daniel R. | Chief Financial Officer | P Purchase | 7,500 | $8.57 | $64,275 |
| Mar 27, 2026 | George Jeffrey P. | Director | P Purchase | 5,592 | $8.92 | $49,890 |
| Mar 27, 2026 | Schimmelpennink Evert B. | President, CEO and Secretary | P Purchase | 28,089 | $8.95 | $251,411 |
| Jan 2, 2026 | Chevallard Daniel R. | Chief Financial Officer | A Award | 14,000 | Not measured | Not measured |
| Jan 2, 2026 | Chevallard Daniel R. | Chief Financial Officer | A Award | 84,200 | Not measured | Not measured |
| Jan 2, 2026 | Odrich Marc | Chief Medical Officer | A Award | 14,000 | Not measured | Not measured |
| Jan 2, 2026 | Odrich Marc | Chief Medical Officer | A Award | 84,200 | Not measured | Not measured |
| Jan 2, 2026 | Olsson Shawn | Chief Commercial Officer | A Award | 14,000 | Not measured | Not measured |
| Jan 2, 2026 | Olsson Shawn | Chief Commercial Officer | A Award | 84,200 | Not measured | Not measured |
| Jan 2, 2026 | Schimmelpennink Evert B. | President, CEO and Secretary | A Award | 358,100 | Not measured | Not measured |
| Nov 17, 2025 | Olsson Shawn | Chief Commercial Officer | M Exercise | 10,000 | Not measured | Not measured |
| Nov 17, 2025 | Olsson Shawn | Chief Commercial Officer | M Exercise | 10,000 | $2.08 | $20,800 |
| Nov 17, 2025 | Olsson Shawn | Chief Commercial Officer | S Sale | 5,788 | $26.37 | $152,612 |
| Nov 17, 2025 | Olsson Shawn | Chief Commercial Officer | S Sale | 4,212 | $25.74 | $108,411 |
| Nov 7, 2025 | Chevallard Daniel R. | Chief Financial Officer | P Purchase | 2,178 | $22.76 | $49,563 |
| Nov 7, 2025 | Chevallard Daniel R. | Chief Financial Officer | P Purchase | 20 | $22.71 | $454 |
| Nov 7, 2025 | MCCOLLUM JAMES W | Director | P Purchase | 10,500 | $22.79 | $239,278 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 57,502 | $46.41 | $2,668,484 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 49,701 | $45.35 | $2,254,174 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 34,405 | $45.35 | $1,560,428 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 83,066 | $46.41 | $3,854,827 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 177 | $47.01 | $8,321 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 123 | $47.01 | $5,783 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 49,479 | $41.59 | $2,057,871 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 132 | $43.30 | $5,716 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 20,148 | $43.00 | $866,441 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 40,907 | $43.00 | $1,759,156 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 24,370 | $41.59 | $1,013,568 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 268 | $43.30 | $11,604 |
| Aug 26, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 43,978 | $38.97 | $1,714,016 |
| Aug 26, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 21,661 | $38.97 | $844,224 |
| Aug 26, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 3,465 | $39.50 | $136,875 |
| Aug 26, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 1,707 | $39.50 | $67,430 |
| Aug 25, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 24,760 | $39.53 | $978,651 |
| Aug 25, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 1,058 | $39.92 | $42,237 |
| Aug 25, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 50,270 | $39.53 | $1,986,947 |
| Aug 25, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 2,149 | $39.92 | $85,791 |
| Aug 22, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 5,668 | $40.59 | $230,064 |
| Aug 22, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 10,076 | $40.03 | $403,339 |
| Aug 22, 2025 | Versant Venture Capital VI, L.P. | 10% Owner | S Sale | 20,493 | $40.03 | $820,329 |
The full Form 4 history is on the LENZ company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.